HKH
HARRIS KUO HAO HUANG
R&D Director
SHANXI ZHENDONG MEDPHARM CO.,LTD.
About me
Registration Type
ATT
Is member of
MPLA (Monophosphoryl Lipid A)
Exhibitorsis attending
Panel: Reshoring US Pharma: The Realities
Conference Theater 1
Jordyn Lee · Antheia
Boosting DSCSA Regulatory Preparedness for FDA’s Drug Supply Chain Security Act Compliance with Copilot Integrated Generative AI/ML
Conference Theater 2
Difficulties Meeting US FDA Regulatory Requirements
Conference Theater 2
Purna Thakker · ADPT Solution
Navigating the Talent Crisis: Strategies for Safeguarding the Workforce of the Future
Conference Theater 2
Raman Sehgal · Molecule to Market
China Drug Master File (DMF) Comparing with U.S. and EU
Conference Theater 2